Publications by Dr Jérémie Nsengimana - ePrints

Browsing publications by Dr Jérémie Nsengimana.

Newcastle Authors	Title	Year
Dr Jérémie Nsengimana	Immune subtyping of melanoma whole slide images using multiple instance learning	2024
Dr Abi Gault Dr Linda Hogarth Dr Kristian Williams Professor Alastair Greystoke Professor Neil Rajan et al.	Monitoring immunE DysregulAtion foLLowing Immune checkpOint-inhibitioN (MEDALLION): protocol for an observational cancer immunotherapy cohort study	2024
Dr Jérémie Nsengimana	Multilevel graph representations of melanoma whole slide images for identifying immune subgroups	2024
Dr Jérémie Nsengimana	Peroxiredonixin-2 represses NRAS-mutated melanoma cells invasion by modulating EMT markers	2024
Dr Jérémie Nsengimana Dr Theophile Bigirumurame	Systemic Inflammation, the peripheral blood transcriptome and primary melanoma	2024
Dr Svetlana Cherlin Dr Theophile Bigirumurame Dr Michael Grayling Dr Jérémie Nsengimana Luke Ouma et al.	Utilising high-dimensional data in randomised clinical trials: a review of methods and practice	2024
Dr Jérémie Nsengimana	GABA regulates electrical activity and tumour initiation in melanoma	2023
Dr Jérémie Nsengimana	Identifying the Transcriptional Drivers of Metastasis Embedded within Localized Melanoma	2023
Dr Jérémie Nsengimana	ROR2 promotes epithelial to mesenchymal transition by hyperactivating ERK in melanoma	2023
Dr Jérémie Nsengimana	Association Study between Polymorphisms in DNA Methylation-Related Genes and Testicular Germ Cell Tumor Risk	2022
Dr Jérémie Nsengimana	Defining novel causal SNPs and linked phenotypes at melanoma-associated loci	2022
Dr Jérémie Nsengimana	Genes regulated by DNA methylation are involved in distinct phenotypes during melanoma progression and are prognostic factors for patients	2022
Dr Jérémie Nsengimana	Ulcerated melanoma: Systems biology evidence of inflammatory imbalance towards pro-tumourigenicity	2022
Dr Jérémie Nsengimana	Cooperation between melanoma cell states promotes metastasis through heterotypic cluster formation	2021
Dr Jérémie Nsengimana	Identification of 22 susceptibility loci associated with testicular germ cell tumors	2021
Dr Jérémie Nsengimana	Inherited duplications of PPP2R3B predispose to nevi and melanoma via C21orf91-driven proliferative phenotype	2021
Dr Jérémie Nsengimana	MX2 mediates establishment of interferon response profile, regulates XAF1, and can sensitize melanoma cell to targeted therapy	2021
Dr Jérémie Nsengimana	ROR2 has a protective role in melanoma by inhibiting Akt activity, cell cycle progression and proliferation	2021
Dr Jérémie Nsengimana	SFPQ promotes an oncogenic transcriptomic state in melanoma	2021
Dr Jérémie Nsengimana	The role of CAF derived exosomal microRNAs in the tumour microenvironment of melanoma	2021
Dr Jérémie Nsengimana	Transcriptional signatures underlying dynamic phenotypic switching and novel disease biomarkers in a linear cellular model of melanoma progression	2021
Dr Jérémie Nsengimana	Tumour gene expression signature in primary melanoma predicts long-term outcomes	2021
Dr Helen Close Dr Jérémie Nsengimana	Expression profiling of single cells and patient cohorts identifies multiple immunosuppressive pathways and an altered NK cell phenotype in glioblastoma	2020
Dr Jérémie Nsengimana	Factors affecting sentinel node metastasis in thin cutaneous melanomas: development and external validation of a predictive nomogram	2020
Dr Jérémie Nsengimana	Gene co-expression and histone modification signatures are associated with melanoma progression, epithelial-to-mesenchimal transition and metastasis	2020
Dr Jérémie Nsengimana	MX 2 is a novel regulator of cell cycle in melanoma cells	2020
Dr Jérémie Nsengimana	Study of the female sex survival advantage in melanoma- a focus on X-linked epigenetic regulators and immune responses in two cohorts	2020
Dr Jérémie Nsengimana Batool Shannan	Application of circulating cell-free tumor DNA profiles for therapeutic monitoring and outcome prediction in genetically heterogeneous metastatic melanoma	2019
Dr Jérémie Nsengimana	Genetic and environmental determinants of immune response to cutaneous melanoma	2019
Dr Jérémie Nsengimana	High-Resolution Copy Number Patterns From Clinically Relevant FFPE Material	2019
Dr Jérémie Nsengimana	Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma	2019
Dr Jérémie Nsengimana	Vitamin D–VDR signaling inhibits Wnt/b-catenin–mediated melanoma progression and promotes antitumor immunity	2019
Dr Jérémie Nsengimana	Comparative genomics reveals that loss of lunatic fringe (LFNG) promotes melanoma metastasis	2018
Dr Jérémie Nsengimana	Large-scale Sequencing of Testicular Germ Cell Tumour (TGCT) Cases Excludes Major TGCT Predisposition Gene	2018
Dr Jérémie Nsengimana	β-Catenin-mediated immune evasion pathway frequently operates in primary cutaneous melanomas	2018
Dr Jérémie Nsengimana	A screen for combination therapies in BRAF/NRAS wild type melanoma identifies nilotinib plus MEK inhibitor as a synergistic combination	2017
Dr Jérémie Nsengimana	Design considerations for genetic linkage and association studies	2017
Dr Jérémie Nsengimana	Functional characterization of a multi-cancer risk locus on chr5p15.33 reveals regulation of TERT by ZNF148	2017
Dr Jérémie Nsengimana	Genomic expression differences between cutaneous cells from red hair color individuals and black hair color individuals based on bioinformatic analysis	2017
Dr Jérémie Nsengimana	Identification of 19 new risk loci and potential regulatory mechanisms influencing susceptibility to testicular germ cell tumor	2017
Dr Jérémie Nsengimana	Identification of a gene signature for discriminating metastatic from primary melanoma using a molecular interaction network approach	2017
Dr Jérémie Nsengimana	Consensus of Melanoma Gene Expression Subtypes Converges on Biological Entities	2016
Amy Lloyd Dr Jérémie Nsengimana	Identification of four new susceptibility loci for testicular germ cell tumour	2015
Dr Jérémie Nsengimana	Independent replication of a melanoma subtype gene signature and evaluation of its prognostic value and biological correlates in a population cohort	2015
Dr Jérémie Nsengimana	Multi-stage genome-wide association study identifies new susceptibility locus for testicular germ cell tumour on chromosome 3q25	2015
Dr Jérémie Nsengimana	Prognostic Significance of Promoter Hypermethylation and Diminished Gene Expression of SYNPO2 in Melanoma	2015
Dr Jérémie Nsengimana	The clinicopathological and gene expression patterns associated with ulceration of primary melanoma	2015
Dr Jérémie Nsengimana	Next-generation sequencing identifies germline MRE11A variants as markers of radiotherapy outcomes in muscle-invasive bladder cancer	2014
Dr Jérémie Nsengimana	Targeting human apurinic/apyrimidinic endonuclease 1 (APE1) in phosphatase and tensin homolog (PTEN) deficient melanoma cells for personalized therapy	2014
Dr Jérémie Nsengimana	Renin–angiotensin system genes and coronary artery calcification	2007